Under a cancer context, it is known that STAT3 signaling regulates the CD5 expression [40], but in the TB context, this signaling has not been clarified; further studies are necessary to identify the molecules involved to favor the expansion of CD5+ B cells in LTB. The gene discussed is CD5; the disease is cancer.